http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 01 Jun 2026 17:24:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CYBIN+INC.++++++++++++++++For%3A+Jun+01/26585119.html si-local-file:///var/storage/secattach/20260601/26585119.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CYBIN+INC.++++++++++++++++For%3A+Jun+01/26585119.html Mon, 01 Jun 2026 17:24:00 -0400 HELP O.37286706 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CYBIN+INC.++++++++++++++++For%3A+Jun+01/26585119.html si-local-file:///var/storage/secattach/20260601/26585119.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CYBIN+INC.++++++++++++++++For%3A+Jun+01/26585119.html Mon, 01 Jun 2026 17:24:00 -0400 HELP O.37286706 http://www.streetinsider.com/Press+Releases/Helus+Pharma+to+Participate+in+the+Jefferies+Global+Healthcare+Conference+in+New+York/26579184.html <ul><li><em><i>Eric So, Interim CEO, to participate in a fireside chat on Thursday, June 4 at 2:35 p.m. EDT</i></em></li></ul> <p align="justify">NEW YORK and TORONTO, June 01, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), today announced that Eric So, Helus Pharma’s Interim Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York, taking place June 2-4, 2026.</p> <p align="justify">The fireside chat will be webcast live on Thursday, June 4, 2026, at http://www.streetinsider.com/Press+Releases/Helus+Pharma+to+Participate+in+the+Jefferies+Global+Healthcare+Conference+in+New+York/26579184.html Mon, 01 Jun 2026 07:30:00 -0400 HELP http://www.streetinsider.com/Globe+Newswire/Helus+Pharma+to+Participate+in+the+Jefferies+Global+Healthcare+Conference+in+New+York/26579184.html <ul><li><em><i>Eric So, Interim CEO, to participate in a fireside chat on Thursday, June 4 at 2:35 p.m. EDT</i></em></li></ul> <p align="justify">NEW YORK and TORONTO, June 01, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), today announced that Eric So, Helus Pharma’s Interim Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York, taking place June 2-4, 2026.</p> <p align="justify">The fireside chat will be webcast live on Thursday, June 4, 2026, at http://www.streetinsider.com/Globe+Newswire/Helus+Pharma+to+Participate+in+the+Jefferies+Global+Healthcare+Conference+in+New+York/26579184.html Mon, 01 Jun 2026 07:30:00 -0400 HELP http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CYBIN+INC.+++++++++++++++++++++++++++++Filed+by%3A+Point72+Asset+Management%2C+L.P./26506454.html si-local-file:///var/storage/secattach/20260515/26506454.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CYBIN+INC.+++++++++++++++++++++++++++++Filed+by%3A+Point72+Asset+Management%2C+L.P./26506454.html Fri, 15 May 2026 16:33:00 -0400 HELP O.37286706 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CYBIN+INC.+++++++++++++++++++++++++++++Filed+by%3A+Point72+Asset+Management%2C+L.P./26506454.html si-local-file:///var/storage/secattach/20260515/26506454.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CYBIN+INC.+++++++++++++++++++++++++++++Filed+by%3A+Point72+Asset+Management%2C+L.P./26506454.html Fri, 15 May 2026 16:33:00 -0400 HELP O.37286706 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++CYBIN+INC.+++++++++++++++++++++++++++++Filed+by%3A+Sirenia+Capital+Management+LP/26499906.html si-local-file:///var/storage/secattach/20260515/26499906.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++CYBIN+INC.+++++++++++++++++++++++++++++Filed+by%3A+Sirenia+Capital+Management+LP/26499906.html Fri, 15 May 2026 08:13:00 -0400 HELP O.37286706 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++CYBIN+INC.+++++++++++++++++++++++++++++Filed+by%3A+Sirenia+Capital+Management+LP/26499906.html si-local-file:///var/storage/secattach/20260515/26499906.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++CYBIN+INC.+++++++++++++++++++++++++++++Filed+by%3A+Sirenia+Capital+Management+LP/26499906.html Fri, 15 May 2026 08:13:00 -0400 HELP O.37286706 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CYBIN+INC.++++++++++++++++For%3A+Apr+30/26425490.html si-local-file:///var/storage/secattach/20260504/26425490.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CYBIN+INC.++++++++++++++++For%3A+Apr+30/26425490.html Mon, 04 May 2026 16:05:00 -0400 HELP O.37286706 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CYBIN+INC.++++++++++++++++For%3A+Apr+30/26425490.html si-local-file:///var/storage/secattach/20260504/26425490.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CYBIN+INC.++++++++++++++++For%3A+Apr+30/26425490.html Mon, 04 May 2026 16:05:00 -0400 HELP O.37286706 http://www.streetinsider.com/Press+Releases/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html <p align="justify">NEW YORK &amp; TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 28, 2026, by Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP), please note references to Veterans Exploring Treatment Solutions (“VETS”) have been removed from the first, third and fourth paragraphs.  The corrected release follows: <br/><br/></p> <p align="center"><strong>Helus</strong><strong> Pharma Partners with TARA Mind to Advance Veteran Mental Health </strong></p> <ul><li><em>Collaboration with leading mental health organization to support HLP003 Phase 3 recruitment and expand outreach in veteran communities following landmark Executive Order on breakthrough mental health treatments<br/><br/></em></li></ul> <p http://www.streetinsider.com/Press+Releases/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html Thu, 30 Apr 2026 19:17:00 -0400 A.06822034 A.17150087 HELP HELP O.20026344 O.37286706 O.49223070 http://www.streetinsider.com/Press+Releases/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html <p align="justify">NEW YORK &amp; TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 28, 2026, by Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP), please note references to Veterans Exploring Treatment Solutions (“VETS”) have been removed from the first, third and fourth paragraphs.  The corrected release follows: <br/><br/></p> <p align="center"><strong>Helus</strong><strong> Pharma Partners with TARA Mind to Advance Veteran Mental Health </strong></p> <ul><li><em>Collaboration with leading mental health organization to support HLP003 Phase 3 recruitment and expand outreach in veteran communities following landmark Executive Order on breakthrough mental health treatments<br/><br/></em></li></ul> <p http://www.streetinsider.com/Press+Releases/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html Thu, 30 Apr 2026 19:17:00 -0400 A.06822034 A.17150087 HELP HELP O.20026344 O.37286706 O.49223070 http://www.streetinsider.com/Press+Releases/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html <p align="justify">NEW YORK &amp; TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 28, 2026, by Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP), please note references to Veterans Exploring Treatment Solutions (“VETS”) have been removed from the first, third and fourth paragraphs.  The corrected release follows: <br/><br/></p> <p align="center"><strong>Helus</strong><strong> Pharma Partners with TARA Mind to Advance Veteran Mental Health </strong></p> <ul><li><em>Collaboration with leading mental health organization to support HLP003 Phase 3 recruitment and expand outreach in veteran communities following landmark Executive Order on breakthrough mental health treatments<br/><br/></em></li></ul> <p http://www.streetinsider.com/Press+Releases/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html Thu, 30 Apr 2026 19:17:00 -0400 A.06822034 A.17150087 HELP HELP O.20026344 O.37286706 O.49223070 http://www.streetinsider.com/Press+Releases/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html <p align="justify">NEW YORK &amp; TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 28, 2026, by Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP), please note references to Veterans Exploring Treatment Solutions (“VETS”) have been removed from the first, third and fourth paragraphs.  The corrected release follows: <br/><br/></p> <p align="center"><strong>Helus</strong><strong> Pharma Partners with TARA Mind to Advance Veteran Mental Health </strong></p> <ul><li><em>Collaboration with leading mental health organization to support HLP003 Phase 3 recruitment and expand outreach in veteran communities following landmark Executive Order on breakthrough mental health treatments<br/><br/></em></li></ul> <p http://www.streetinsider.com/Press+Releases/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html Thu, 30 Apr 2026 19:17:00 -0400 A.06822034 A.17150087 HELP HELP O.20026344 O.37286706 O.49223070 http://www.streetinsider.com/Press+Releases/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html <p align="justify">NEW YORK &amp; TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 28, 2026, by Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP), please note references to Veterans Exploring Treatment Solutions (“VETS”) have been removed from the first, third and fourth paragraphs.  The corrected release follows: <br/><br/></p> <p align="center"><strong>Helus</strong><strong> Pharma Partners with TARA Mind to Advance Veteran Mental Health </strong></p> <ul><li><em>Collaboration with leading mental health organization to support HLP003 Phase 3 recruitment and expand outreach in veteran communities following landmark Executive Order on breakthrough mental health treatments<br/><br/></em></li></ul> <p http://www.streetinsider.com/Press+Releases/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html Thu, 30 Apr 2026 19:17:00 -0400 A.06822034 A.17150087 HELP HELP O.20026344 O.37286706 O.49223070 http://www.streetinsider.com/Press+Releases/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html <p align="justify">NEW YORK &amp; TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 28, 2026, by Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP), please note references to Veterans Exploring Treatment Solutions (“VETS”) have been removed from the first, third and fourth paragraphs.  The corrected release follows: <br/><br/></p> <p align="center"><strong>Helus</strong><strong> Pharma Partners with TARA Mind to Advance Veteran Mental Health </strong></p> <ul><li><em>Collaboration with leading mental health organization to support HLP003 Phase 3 recruitment and expand outreach in veteran communities following landmark Executive Order on breakthrough mental health treatments<br/><br/></em></li></ul> <p http://www.streetinsider.com/Press+Releases/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html Thu, 30 Apr 2026 19:17:00 -0400 A.06822034 A.17150087 HELP HELP O.20026344 O.37286706 O.49223070 http://www.streetinsider.com/Press+Releases/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html <p align="justify">NEW YORK &amp; TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 28, 2026, by Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP), please note references to Veterans Exploring Treatment Solutions (“VETS”) have been removed from the first, third and fourth paragraphs.  The corrected release follows: <br/><br/></p> <p align="center"><strong>Helus</strong><strong> Pharma Partners with TARA Mind to Advance Veteran Mental Health </strong></p> <ul><li><em>Collaboration with leading mental health organization to support HLP003 Phase 3 recruitment and expand outreach in veteran communities following landmark Executive Order on breakthrough mental health treatments<br/><br/></em></li></ul> <p http://www.streetinsider.com/Press+Releases/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html Thu, 30 Apr 2026 19:17:00 -0400 A.06822034 A.17150087 HELP HELP O.20026344 O.37286706 O.49223070 http://www.streetinsider.com/Globe+Newswire/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html <p align="justify">NEW YORK &amp; TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 28, 2026, by Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP), please note references to Veterans Exploring Treatment Solutions (“VETS”) have been removed from the first, third and fourth paragraphs.  The corrected release follows: <br/><br/></p> <p align="center"><strong>Helus</strong><strong> Pharma Partners with TARA Mind to Advance Veteran Mental Health </strong></p> <ul><li><em>Collaboration with leading mental health organization to support HLP003 Phase 3 recruitment and expand outreach in veteran communities following landmark Executive Order on breakthrough mental health treatments<br/><br/></em></li></ul> <p http://www.streetinsider.com/Globe+Newswire/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html Thu, 30 Apr 2026 19:17:00 -0400 A.06822034 A.17150087 HELP HELP O.20026344 O.37286706 O.49223070 http://www.streetinsider.com/Globe+Newswire/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html <p align="justify">NEW YORK &amp; TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 28, 2026, by Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP), please note references to Veterans Exploring Treatment Solutions (“VETS”) have been removed from the first, third and fourth paragraphs.  The corrected release follows: <br/><br/></p> <p align="center"><strong>Helus</strong><strong> Pharma Partners with TARA Mind to Advance Veteran Mental Health </strong></p> <ul><li><em>Collaboration with leading mental health organization to support HLP003 Phase 3 recruitment and expand outreach in veteran communities following landmark Executive Order on breakthrough mental health treatments<br/><br/></em></li></ul> <p http://www.streetinsider.com/Globe+Newswire/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html Thu, 30 Apr 2026 19:17:00 -0400 A.06822034 A.17150087 HELP HELP O.20026344 O.37286706 O.49223070 http://www.streetinsider.com/Globe+Newswire/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html <p align="justify">NEW YORK &amp; TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 28, 2026, by Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP), please note references to Veterans Exploring Treatment Solutions (“VETS”) have been removed from the first, third and fourth paragraphs.  The corrected release follows: <br/><br/></p> <p align="center"><strong>Helus</strong><strong> Pharma Partners with TARA Mind to Advance Veteran Mental Health </strong></p> <ul><li><em>Collaboration with leading mental health organization to support HLP003 Phase 3 recruitment and expand outreach in veteran communities following landmark Executive Order on breakthrough mental health treatments<br/><br/></em></li></ul> <p http://www.streetinsider.com/Globe+Newswire/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html Thu, 30 Apr 2026 19:17:00 -0400 A.06822034 A.17150087 HELP HELP O.20026344 O.37286706 O.49223070 http://www.streetinsider.com/Globe+Newswire/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html <p align="justify">NEW YORK &amp; TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 28, 2026, by Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP), please note references to Veterans Exploring Treatment Solutions (“VETS”) have been removed from the first, third and fourth paragraphs.  The corrected release follows: <br/><br/></p> <p align="center"><strong>Helus</strong><strong> Pharma Partners with TARA Mind to Advance Veteran Mental Health </strong></p> <ul><li><em>Collaboration with leading mental health organization to support HLP003 Phase 3 recruitment and expand outreach in veteran communities following landmark Executive Order on breakthrough mental health treatments<br/><br/></em></li></ul> <p http://www.streetinsider.com/Globe+Newswire/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html Thu, 30 Apr 2026 19:17:00 -0400 A.06822034 A.17150087 HELP HELP O.20026344 O.37286706 O.49223070 http://www.streetinsider.com/Globe+Newswire/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html <p align="justify">NEW YORK &amp; TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 28, 2026, by Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP), please note references to Veterans Exploring Treatment Solutions (“VETS”) have been removed from the first, third and fourth paragraphs.  The corrected release follows: <br/><br/></p> <p align="center"><strong>Helus</strong><strong> Pharma Partners with TARA Mind to Advance Veteran Mental Health </strong></p> <ul><li><em>Collaboration with leading mental health organization to support HLP003 Phase 3 recruitment and expand outreach in veteran communities following landmark Executive Order on breakthrough mental health treatments<br/><br/></em></li></ul> <p http://www.streetinsider.com/Globe+Newswire/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html Thu, 30 Apr 2026 19:17:00 -0400 A.06822034 A.17150087 HELP HELP O.20026344 O.37286706 O.49223070 http://www.streetinsider.com/Globe+Newswire/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html <p align="justify">NEW YORK &amp; TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 28, 2026, by Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP), please note references to Veterans Exploring Treatment Solutions (“VETS”) have been removed from the first, third and fourth paragraphs.  The corrected release follows: <br/><br/></p> <p align="center"><strong>Helus</strong><strong> Pharma Partners with TARA Mind to Advance Veteran Mental Health </strong></p> <ul><li><em>Collaboration with leading mental health organization to support HLP003 Phase 3 recruitment and expand outreach in veteran communities following landmark Executive Order on breakthrough mental health treatments<br/><br/></em></li></ul> <p http://www.streetinsider.com/Globe+Newswire/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html Thu, 30 Apr 2026 19:17:00 -0400 A.06822034 A.17150087 HELP HELP O.20026344 O.37286706 O.49223070 http://www.streetinsider.com/Globe+Newswire/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html <p align="justify">NEW YORK &amp; TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 28, 2026, by Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP), please note references to Veterans Exploring Treatment Solutions (“VETS”) have been removed from the first, third and fourth paragraphs.  The corrected release follows: <br/><br/></p> <p align="center"><strong>Helus</strong><strong> Pharma Partners with TARA Mind to Advance Veteran Mental Health </strong></p> <ul><li><em>Collaboration with leading mental health organization to support HLP003 Phase 3 recruitment and expand outreach in veteran communities following landmark Executive Order on breakthrough mental health treatments<br/><br/></em></li></ul> <p http://www.streetinsider.com/Globe+Newswire/CORRECTION%3A+Helus+Pharma+Partners+with+TARA+Mind+to+Advance+Veteran+Mental+Health%C2%A0/26410719.html Thu, 30 Apr 2026 19:17:00 -0400 A.06822034 A.17150087 HELP HELP O.20026344 O.37286706 O.49223070 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CYBIN+INC.++++++++++++++++For%3A+Apr+30/26406926.html si-local-file:///var/storage/secattach/20260430/26406926.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CYBIN+INC.++++++++++++++++For%3A+Apr+30/26406926.html Thu, 30 Apr 2026 15:46:00 -0400 HELP O.37286706